Company Analysis PeptiDream Inc.
1. Summary
Advantages
- The stock's return over the last year (39.99%) is higher than the sector average (-5.32%).
- The company's current efficiency (ROE=7.99%) is higher than the sector average (ROE=-10.46%)
Disadvantages
- Price (1953.5 Β₯) is higher than fair price (386.84 Β₯)
- Dividends (0%) are below the sector average (2.62%).
- Current debt level 33.48% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| PeptiDream Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -31.7% | -0% | 0.2% |
| 90 days | -30.2% | -0% | 10.5% |
| 1 year | 40% | -5.3% | 21.9% |
4587 vs Sector: PeptiDream Inc. has outperformed the "Healthcare" sector by 45.31% over the past year.
4587 vs Market: PeptiDream Inc. has outperformed the market by 18.12% over the past year.
Stable price: 4587 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4587 with weekly volatility of 0.769% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1953.5 Β₯) is higher than the fair price (386.84 Β₯).
Price is higher than fair: The current price (1953.5 Β₯) is 80.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (59.17) is lower than that of the sector as a whole (111.03).
P/E vs Market: The company's P/E (59.17) is lower than that of the market as a whole (101.86).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.73) is lower than that of the sector as a whole (70.29).
P/BV vs Market: The company's P/BV (4.73) is lower than that of the market as a whole (67.75).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (6.26) is lower than that of the sector as a whole (75.03).
P/S vs Market: The company's P/S indicator (6.26) is lower than that of the market as a whole (67.66).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.04) is lower than that of the sector as a whole (76.71).
EV/Ebitda vs Market: The company's EV/Ebitda (19.04) is lower than that of the market as a whole (113.45).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -144.29% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-144.29%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.55%).
5.4. ROE
ROE vs Sector: The company's ROE (7.99%) is higher than that of the sector as a whole (-10.46%).
ROE vs Market: The company's ROE (7.99%) is higher than that of the market as a whole (2.63%).
5.5. ROA
ROA vs Sector: The company's ROA (4.52%) is higher than that of the sector as a whole (-10.03%).
ROA vs Market: The company's ROA (4.52%) is higher than that of the market as a whole (3.68%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (9.09%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.77%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.62%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
